HIV Drug Shows Potential To Combat Genetic Form of Dystonia in Preclinical Study
A new UF study found that an FDA-approved medication to treat HIV restored multiple brain abnormalities in a mouse model of a genetic form of dystonia.
etectRx Announces Launch of MyTPill Study To Address Medication Adherence Among HIV+ Prescription Opioid Users
UF Innovate | The Hub resident company etectRx, Inc., a privately-held digital health company, announced the launch of a study to monitor antiretroviral therapy adherence among prescription opioid users living with HIV.
